Caffeic Acid and Its Derivatives: Antimicrobial Drugs toward Microbial Pathogens. 2021

Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
Institute of Food Science, Pukyong National University, Busan 48513, South Korea.

Caffeic acid is a plant-derived compound that is classified as hydroxycinnamic acid which contains both phenolic and acrylic functional groups. Caffeic acid has been greatly employed as an alternative strategy to combat microbial pathogenesis and chronic infection induced by microbes such as bacteria, fungi, and viruses. Similarly, several derivatives of caffeic acid such as sugar esters, organic esters, glycosides, and amides have been chemically synthesized or naturally isolated as potential antimicrobial agents. To overcome the issue of water insolubility and poor stability, caffeic acid and its derivative have been utilized either in conjugation with other bioactive molecules or in nanoformulation. Besides, caffeic acid and its derivatives have also been applied in combination with antibiotics or photoirradiation to achieve a synergistic mode of action. The present review describes the antimicrobial roles of caffeic acid and its derivatives exploited either in free form or in combination or in nanoformulation to kill a diverse range of microbial pathogens along with their mode of action. The chemistry employed for the synthesis of the caffeic acid derivatives has been discussed in detail as well.

UI MeSH Term Description Entries
D002109 Caffeic Acids A class of phenolic acids related to chlorogenic acid, p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation. Acids, Caffeic
D003373 Coumaric Acids Hydroxycinnamic acid and its derivatives. Act as activators of the indoleacetic acid oxidizing system, thereby producing a decrease in the endogenous level of bound indoleacetic acid in plants. Coumaric Acid,Hydroxycinnamic Acid,Hydroxycinnamic Acids,Acid, Coumaric,Acid, Hydroxycinnamic,Acids, Coumaric,Acids, Hydroxycinnamic
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
January 2024, International journal of molecular sciences,
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
October 2017, Food research international (Ottawa, Ont.),
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
May 2023, Molecules (Basel, Switzerland),
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
January 2019, Current topics in medicinal chemistry,
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
January 2020, Frontiers in physiology,
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
February 2003, Guang pu xue yu guang pu fen xi = Guang pu,
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
October 2014, Molecules (Basel, Switzerland),
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
January 2021, Drug design, development and therapy,
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
April 1989, Chemical & pharmaceutical bulletin,
Fazlurrahman Khan, and Nilushi Indika Bamunuarachchi, and Nazia Tabassum, and Young-Mog Kim
January 2014, Research in pharmaceutical sciences,
Copied contents to your clipboard!